EE04296B1 - Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini - Google Patents

Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini

Info

Publication number
EE04296B1
EE04296B1 EEP200100014A EEP200100014A EE04296B1 EE 04296 B1 EE04296 B1 EE 04296B1 EE P200100014 A EEP200100014 A EE P200100014A EE P200100014 A EEP200100014 A EE P200100014A EE 04296 B1 EE04296 B1 EE 04296B1
Authority
EE
Estonia
Prior art keywords
sertraline
agent containing
antidepressant agent
containing pramipexole
pramipexole
Prior art date
Application number
EEP200100014A
Other languages
English (en)
Estonian (et)
Inventor
Maj Jerzy
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200100014A publication Critical patent/EE200100014A/xx
Publication of EE04296B1 publication Critical patent/EE04296B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100014A 1998-07-07 1999-07-02 Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini EE04296B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004595 WO2000002542A2 (de) 1998-07-07 1999-07-02 Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum

Publications (2)

Publication Number Publication Date
EE200100014A EE200100014A (et) 2002-06-17
EE04296B1 true EE04296B1 (et) 2004-06-15

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100014A EE04296B1 (et) 1998-07-07 1999-07-02 Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini

Country Status (33)

Country Link
US (1) US6255329B1 (xx)
EP (1) EP1093369B1 (xx)
JP (1) JP2002520273A (xx)
KR (1) KR100557692B1 (xx)
CN (1) CN1230168C (xx)
AR (1) AR019896A1 (xx)
AT (1) ATE228365T1 (xx)
AU (1) AU762128B2 (xx)
BG (1) BG64972B1 (xx)
BR (1) BR9911768A (xx)
CA (1) CA2336833C (xx)
CZ (1) CZ294087B6 (xx)
DE (2) DE19830201A1 (xx)
DK (1) DK1093369T3 (xx)
EA (1) EA003142B1 (xx)
EE (1) EE04296B1 (xx)
ES (1) ES2183583T3 (xx)
HK (1) HK1037976A1 (xx)
HU (1) HUP0103922A3 (xx)
ID (1) ID27776A (xx)
IL (1) IL140603A0 (xx)
MY (1) MY117969A (xx)
NO (1) NO20010064L (xx)
NZ (1) NZ509729A (xx)
PL (1) PL195043B1 (xx)
PT (1) PT1093369E (xx)
RS (1) RS49795B (xx)
SK (1) SK284923B6 (xx)
TR (1) TR200100146T2 (xx)
TW (1) TW592698B (xx)
WO (1) WO2000002542A2 (xx)
YU (1) YU401A (xx)
ZA (1) ZA200100090B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006162A1 (de) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Mittel mit antidepressiver wirkung, mit pramipexol und einem weiteren antidepressivum
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
PL374310A1 (en) * 2001-12-11 2005-10-03 University Of Virginia Patent Foundation Use of pramipexole to treat amyotrophic lateral sclerosis
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
CA2554616A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
ES2334061T3 (es) * 2005-08-15 2010-03-04 University Of Virginia Patent Foundation Neurorrestauracion con pramipexol r(+).
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
ATE537826T1 (de) 2006-05-16 2012-01-15 Knopp Neurosciences Inc Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
US8519148B2 (en) 2007-03-14 2013-08-27 Knopp Neurosciences, Inc. Synthesis of chirally purified substituted benzothiazole diamines
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
US20110190356A1 (en) * 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
EP2341912B1 (en) 2008-09-05 2014-01-22 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (adhd)
CA2760527A1 (en) * 2009-04-30 2010-11-04 Supernus Pharmaceuticals, Inc. Method of treatment of depression
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
EP2812074B1 (en) 2012-02-08 2023-05-10 Supernus Pharmaceuticals, Inc. Modified release formulations of viloxazine
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
PT3019167T (pt) 2013-07-12 2021-03-04 Knopp Biosciences Llc Tratamento de níveis elevados de eosinófilos e/ou basófilos
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
US9642840B2 (en) 2013-08-13 2017-05-09 Knopp Biosciences, Llc Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
AU2014306597B2 (en) 2013-08-13 2018-05-17 Knopp Biosciences Llc Compositions and methods for treating chronic urticaria
CN110730662A (zh) 2017-04-10 2020-01-24 才思治疗公司 用于治疗共核蛋白病的nk1-拮抗剂组合和方法
KR20200026920A (ko) 2017-06-30 2020-03-11 체이스 테라퓨틱스 코포레이션 우울증을 치료하기 위한 nk-1 길항제 조성물 및 우울증 치료에 사용하는 방법
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
EP0186087B1 (de) * 1984-12-22 1989-08-23 Dr. Karl Thomae GmbH Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
JP3118467B2 (ja) * 1996-03-29 2000-12-18 ファイザー インク. 5―ht1aおよび/または5―ht1d受容体の選択的(アンタ)アゴニストとしてのベンジル(イデン)―ラクタム誘導体、その調製法及びその使用法
EP0942732B1 (en) * 1996-12-02 2004-11-17 MERCK SHARP & DOHME LTD. Use of nk-1 receptor antagonists for treating movement disorders
EP1047436B1 (en) * 1998-01-13 2009-10-21 Synchroneuron, LLC N-acetylhomotaurinates for use in treating hyperkinesias

Also Published As

Publication number Publication date
EP1093369B1 (de) 2002-11-27
NO20010064D0 (no) 2001-01-05
KR100557692B1 (ko) 2006-03-07
SK112001A3 (en) 2001-10-08
AU5030399A (en) 2000-02-01
EA200100084A1 (ru) 2001-08-27
RS49795B (sr) 2008-06-05
CZ200177A3 (en) 2001-06-13
BG105112A (en) 2001-10-31
AR019896A1 (es) 2002-03-20
ID27776A (id) 2001-04-26
JP2002520273A (ja) 2002-07-09
EP1093369A2 (de) 2001-04-25
HUP0103922A2 (hu) 2002-03-28
PL195043B1 (pl) 2007-08-31
EE200100014A (et) 2002-06-17
MY117969A (en) 2004-08-30
NO20010064L (no) 2001-03-02
HK1037976A1 (en) 2002-03-01
CA2336833A1 (en) 2000-01-20
DK1093369T3 (da) 2002-12-16
PT1093369E (pt) 2003-03-31
AU762128B2 (en) 2003-06-19
KR20010079491A (ko) 2001-08-22
DE59903556D1 (de) 2003-01-09
US6255329B1 (en) 2001-07-03
ZA200100090B (en) 2002-04-04
BG64972B1 (bg) 2006-11-30
PL345842A1 (en) 2002-01-14
CA2336833C (en) 2008-09-23
EA003142B1 (ru) 2003-02-27
YU401A (sh) 2003-10-31
CN1230168C (zh) 2005-12-07
IL140603A0 (en) 2002-02-10
ES2183583T3 (es) 2003-03-16
WO2000002542A3 (de) 2000-06-22
ATE228365T1 (de) 2002-12-15
WO2000002542A2 (de) 2000-01-20
BR9911768A (pt) 2001-04-03
SK284923B6 (sk) 2006-02-02
NZ509729A (en) 2003-06-30
CN1308533A (zh) 2001-08-15
TW592698B (en) 2004-06-21
CZ294087B6 (cs) 2004-10-13
DE19830201A1 (de) 2000-01-13
TR200100146T2 (tr) 2001-07-23
HUP0103922A3 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
EE04296B1 (et) Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini
ID28787A (id) 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya
EE200000766A (et) Ravimkoostis, mis sisaldab COX-2 inhibiitorit ja iNOS inhibiitorit
ID30393A (id) Senyawa tienopirimidina, pembuatan dan penggunaannya
NO20005503L (no) Ny anvendelse
ID22957A (id) Senyawa dan penggunaannya
DE69732778D1 (de) Weiche nitrilkautchuk-zusammensetzung
MA26866A1 (fr) Agents antibacteriens consistant en 3-aminoquinazoline-2,4-diones
DE69929047D1 (de) Haarbehandlungsmittel
NO20022334L (no) Ny sammensetning og anvendelse
DE69919970D1 (de) Axiallüfter
NL1016224A1 (nl) Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
FI981614A (fi) Laakerin kunnon evakuointi
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
DE69822124D1 (de) Axiallüfter
EE04297B1 (et) Budesoniidi ja formoterooli uus kasutamine
BR9900685B1 (pt) composição sólida desodorante e utilização cosmética de uma composição sólida.
ID27922A (id) KOMPOSISI FARMASETIKAL DAN PENGGUNAAN DARI ANDROST-5-ENA-3β, 17β-DIOL
DE69921931D1 (de) Axiallüfter
NO20001847D0 (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
IS5951A (is) 5HT1 mótlyf fyrir meðferð gegn þunglyndi
DZ2547A1 (fr) Formes posologiques de sertraline à libération prolongée.
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
NO20010654L (no) Ny anvendelse av taxoidderivater
MA26666A1 (fr) Antioxide, composition antiproliferee, y compris carnitine et carotenoide.

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090702